UCB and Newbridge Pharmaceuticals Partner for Middle East and African Markets – PharmaLive (press release) (subscription)

by admin on November 22, 2012

UCB and Newbridge Pharmaceuticals Partner for Middle East and African Markets
PharmaLive (press release) (subscription)
Neupro® (rotigotine)in the US is indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome (RLS). For more information about Neupro visit www.neupro.com.

and more »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: